Albumin mass balance and markers of endothelial injury in pancreatic surgery
Not Applicable
Recruiting
- Conditions
- pancreatic cancerendothelial injuryOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
- Registration Number
- ACTRN12616001381471
- Lead Sponsor
- Ake Norberg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Patient scheduled for pancreatoduodenectomy with benign and malignant diagnosis, respectively
Written informed consent
Exclusion Criteria
Patients scheduled for major vascular surgery during the pancreatoduodenectomy.
Outliers, due to change in surgical procedure or profuse bleeding.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method cumulative perioperative albumin shift, i.e. loss of albumin from the blood not explained by bleeding[end of surgery (compared to baseline prior to surgery when cumulative perioperative albumin shift per definition is zero)]
- Secondary Outcome Measures
Name Time Method